RAPT THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

ITEM 7.01 REGULATION FD DISCLOSURE

RAPT Therapeutics, Inc. (the "Company") is filing the investor presentation slides (the "Corporate Presentation") attached hereto as Exhibit 99.1 to this Current Report on Form 8-K, which the Company may use from time to time in conversations with investors and analysts.

The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section. The information shall not be deemed incorporated by reference into any other filing with the Securities and Exchange Commission made by the Company, regardless of any general incorporation language in such filing.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits



                      Exhibit
                      Number    Exhibit Description

                      99.1        Corporate Presentation

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses